Clincosm LogoSign in Get a demo

esophageal diseases

Showing 1 - 25 of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Diseases Trial (Cellspan™ Esophageal Implant-Adult (CEI))

Not yet recruiting
  • Esophageal Diseases
  • Cellspan™ Esophageal Implant-Adult (CEI)
  • (no location specified)
May 26, 2023

Esophagus Cancer, Esophageal Cancer, Esophageal Tumors Trial in Pittsburgh (ActivSight)

Not yet recruiting
  • Esophagus Cancer
  • +9 more
  • ActivSight
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center - Dept of Cardiothoracic
Jan 31, 2023

Esophageal Cancer Risk Registry

Recruiting
  • Esophageal Cancer
  • +4 more
  • Survey of client health, personal habits, family history
  • +3 more
  • Pittsburgh, Pennsylvania
    Department of Cardiothoracic Surgery
Jan 23, 2023

Barrett Esophagus, Gastro Esophageal Reflux, Esophageal Dysplasia Trial in Lake Success

Recruiting
  • Barrett Esophagus
  • +3 more
    • Lake Success, New York
      ProHEALTH Care Associates, LLP
    Nov 29, 2022

    Esophageal Tumors, Esophageal Diseases, Digestive System Tumors Trial (Camrelizumab, Paclitaxel, Platinum)

    Not yet recruiting
    • Esophageal Neoplasms
    • +2 more
    • (no location specified)
    Nov 20, 2022

    Reflux Esophagitis, Gastroesophageal Reflux, Esophagitis Trial in Shanghai (Anaprazole sodium 40 mg, Anaprazole sodium 60 mg,

    Not yet recruiting
    • Reflux Esophagitis
    • +6 more
    • Anaprazole sodium 40 mg
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Changhai Hospital
    Nov 1, 2022

    Esophageal Diseases Trial in Shanghai (ds-MCE and EGD)

    Recruiting
    • Esophageal Diseases
    • ds-MCE and EGD
    • Shanghai, China
    • +6 more
    Jul 19, 2022

    Barrett Esophagus, Gastroesophageal Reflux, Esophageal Dysplasia Trial in Chapel Hill

    Recruiting
    • Barrett Esophagus
    • +3 more
      • Chapel Hill, North Carolina
        University of North Carolina at Chapel Hill
      Jul 19, 2022

      ERAS, Esophageal Diseases Trial in Moscow (esophagectomy with simultaneous reconstruction)

      Recruiting
      • ERAS
      • Esophageal Diseases
      • esophagectomy with simultaneous reconstruction
      • Moscow, Russian Federation
      • +1 more
      Apr 2, 2022

      Twenty Four Hour Ambulatory pH & Impedance Testing: Normative

      Recruiting
      • Esophageal Diseases
      • +2 more
      • 24 hour pH & impedance monitoring
      • Hyderabad, Telangana, India
        AIG Hospitals
      Feb 15, 2022

      Esophageal Squamous Cell Carcinoma, Esophageal Tumors, Esophageal Diseases Trial (Anlotinib HCl, TQB2450)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma
      • +10 more
      • (no location specified)
      Feb 19, 2022

      Stomach Tumor, Gastrointestinal Tumors, Digestive System Tumor Trial in Havana (Ocoxin-Viusid®)

      Recruiting
      • Stomach Neoplasm
      • +9 more
      • Ocoxin-Viusid®
      • Havana, La Habana, Cuba
        National Institute of Oncology and Radiobiology (INOR)
      Oct 20, 2021

      Esophageal Diseases Trial in Shanghai (ultrasound capsule endoscopy)

      Recruiting
      • Esophageal Diseases
      • ultrasound capsule endoscopy
      • Shanghai, Shanghai, China
        Changhai Hospital
      Sep 30, 2021

      Esophageal Diseases, Esophagus SCC Trial in Moshi (Cytosponge™)

      Completed
      • Esophageal Diseases
      • Esophagus SCC
      • Cytosponge™
      • Moshi, Tanzania
        Majengo Unit, Kilimanjaro Clinical Research Institute
      Aug 24, 2021

      Perforation Esophagus, Esophageal Cancer, Esophageal Achalasia Trial in Cologne (VACStent)

      Active, not recruiting
      • Perforation Esophagus
      • +3 more
      • VACStent
      • Cologne, NRW, Germany
        University Hospital of Cologne
      Jul 29, 2021

      Esophageal Tumor, Esophageal Diseases, Esophageal Squamous Cell Carcinoma Trial in Shenzhen (itraconazole)

      Recruiting
      • Esophageal Neoplasm
      • +2 more
      • Shenzhen, Guangdong, China
        National Cancer Center/National Clinical Research Center for Can
      Oct 13, 2020

      Esophageal Tumors, Esophageal Diseases, Esophageal Squamous Cell Carcinoma Trial in Hangzhou (Radiation, SHR-1210)

      Completed
      • Esophageal Neoplasms
      • +2 more
      • Hangzhou, Zhejiang, China
        Hangzhou Cancer Hospital
      Aug 13, 2020

      Esophageal Diseases Trial in London (esophageal cooling device (Attune Medical, Chicago, IL), Standard esophageal temperature

      Unknown status
      • Esophageal Diseases
      • esophageal cooling device (Attune Medical, Chicago, IL)
      • Standard esophageal temperature probe
      • London, United Kingdom
        St.George's Hospital
      Dec 30, 2019

      Esophageal Diseases Trial in Philadelphia (Dronabinol, Placebo)

      Withdrawn
      • Esophageal Diseases
      • Philadelphia, Pennsylvania
        Temple University Hospital
      Sep 25, 2019

      Atrial Fibrillation, Catheter Ablation, Esophageal Fistula Trial in Barcelona (EnsoETM)

      Unknown status
      • Atrial Fibrillation
      • +4 more
      • EnsoETM
      • Barcelona, Spain
        Hospital de la Santa Creu i Sant Pau
      Mar 27, 2019

      Esophageal and Foregut Disorders With WATS vs. 4-Quadrant

      Completed
      • GERD
      • +3 more
        • Portland, Oregon
          Providence Portland Medical Center
        Feb 27, 2019

        Men With High Risk for Esophageal Disorders

        Completed
        • Esophageal Diseases
          • Birmingham, Alabama
            University of Alabama at Birmingham
          Mar 6, 2018

          Gastric Disease, Intestinal Disease, Pancreatic Diseases Trial in Cairo (Endoscopic Ultrasound)

          Unknown status
          • Gastric Disease
          • +3 more
          • Endoscopic Ultrasound
          • Cairo, Egypt
            Tanta university hospital
          Aug 27, 2017

          Esophageal Tumors, Esophageal Diseases Trial in Hangzhou (3-DCRT or IMRT radiation, anti-PD-1 antibody SHR-1210)

          Unknown status
          • Esophageal Neoplasms
          • Esophageal Diseases
          • 3-DCRT or IMRT radiation
          • anti-PD-1 antibody SHR-1210
          • Hangzhou, Zhejiang, China
            Hangzhou Cancer Hospital
          Aug 3, 2017

          Esophageal Tumors, Esophageal Diseases, Digestive System Diseases Trial in Hangzhou (peptide specific CTL)

          Unknown status
          • Esophageal Neoplasms
          • +2 more
          • peptide specific CTL
          • Hangzhou, Zhejiang, China
            Hangzhou Cancer Hospital
          Aug 3, 2017